DFB Pharmaceuticals

Practical Innovationsfor Life.

We aim our entrepreneurial talent on the practical innovation of healthcare technologies and businesses.

DFB Pharmaceuticals is a private investment group focused on building healthcare and life science operating businesses, technologies, and products. Since 1990, DFB and its principals have established a successful track record of creating value by building businesses through strategic acquisitions, product development, brand building, and operational expertise.

We own and operate Phyton Biotech®, the world’s first and only company to harness plant cell fermentation (PCF®) technology for development and commercialization of plant-derived pharmaceuticals, and the world’s largest commercial provider of high-quality Paclitaxel and Docetaxel API via PCF®.